Boston Scientific Corp. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Boston Scientific Corp. (BSX) shares fell 1.32% to $44.03 on Friday, underperforming the broader market and snapping a two-day winning streak. The decline occurred during a dismal trading session where the S&P 500 dropped 1.01% and the Dow Jones Industrial Average fell 0.77%. BSX closed 59.79% below its 52-week high of $109.50 reached in September.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) shed 1.32% to $44.03 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.01% to 7,457.69 and Dow Jones Industrial Average falling 0.77% to 52,146.42.
The stock's fall snapped a two-day winning streak.
Boston Scientific Corp. closed 59.79% below its 52-week high of $109.50, which the company reached on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Abbott Laboratories (ABT) rose 1.87% to $100.68, Medtronic PLC (MDT) fell 0.43% to $83.20, and Stryker Corp. (SYK) fell 3.42% to $319.87.
Data source: Dow Jones Market Data, FactSet. Data compiled July 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-17-26 1645ET